| CXHS1300061 | 安立生坦 | ambrisentan | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2013-05-08 | 连云港润众制药有限公司 | Lianyungang Runzhong Pharmaceutical Co Ltd | Certificate Issued | 2015-12-30 | view |
| CYHS1700137 | 安立生坦 | ambrisentan | Active ingredient | Chemical Drugs(3) | Generic Drug | 2017-07-14 | 连云港润众制药有限公司 | Lianyungang Runzhong Pharmaceutical Co Ltd | In Review | 2017-07-12 | view |
| CXHS1200156 | 安立生坦 | ambrisentan | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2012-07-18 | 连云港宏创药业有限公司 | Lianyungang Hongchuang Pharmaceutical Co Ltd | Certificate Issued | 2015-11-13 | view |
| JYHB2001889 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-25 | view |
| JYHB2000484 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-05-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-07-29 | view |
| JYHB1200784 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2012-07-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-07-08 | view |
| JYHB2000485 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-05-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-07-29 | view |
| JYHZ2000285 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
| JYHB2001888 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2020-09-25 | view |
| JYHB1900843 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2019-07-31 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-02-03 | view |
| JYHZ2000284 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
| JYHB1200964 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2012-09-28 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-07-08 | view |
| JYHB1501102 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2015-08-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHB2001439 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-09-01 | view |
| JYHB1200785 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2012-07-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-07-08 | view |
| JYHZ1500178 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2015-06-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2016-08-18 | view |
| JYHB1200966 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2012-09-28 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2014-07-08 | view |
| JYHB1501103 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2015-08-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHB2001438 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-09-01 | view |
| JYHZ1500179 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2015-05-16 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2016-08-18 | view |
